Product Information
HUMIRA PEN 40 MG/0.8 ML is a brand product labeled by AbbVie Inc., priced at $3366.8735 per EA under NDC 00074433902. Its NADAC has been published 665 times since Nov 28, 2013.
Manufacturer
AbbVie Inc.NDC
00074433902
Classification
Brand
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Biologic (BLA)
FDA Application
BLA125057On Market Since
6/23/2006
Price Statistics
The NADAC for HUMIRA PEN 40 MG/0.8 ML has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 193.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3366.8735 per EA |
|---|---|
| All-time high | $3369.6853 (Mar 13, 2024) |
| All-time low | $1148.0241 (Nov 28, 2013) |
| 52-week high | $3366.8735 |
| 52-week low | $3363.9877 |
| Median price | $2707.8004 |
| Average price | $2577.4085 |
| Largest weekly change | +9.9% (Jan 27, 2016) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HUMIRA PEN 40 MG/0.8 ML?
The current National Average Drug Acquisition Cost (NADAC) for HUMIRA PEN 40 MG/0.8 ML, manufactured by AbbVie Inc., is $3366.8735 per EA (NDC 00074433902), effective Aug 19, 2026.
How has the price of HUMIRA PEN 40 MG/0.8 ML changed over time?
Over the history we have for it, the NADAC for HUMIRA PEN 40 MG/0.8 ML has risen 193.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HUMIRA PEN 40 MG/0.8 ML?
Since Nov 28, 2013, the NADAC for HUMIRA PEN 40 MG/0.8 ML has ranged from a low of $1148.0241 (Nov 28, 2013) to a high of $3369.6853 (Mar 13, 2024), with a median of $2707.8004 per EA.
Are there cheaper alternatives to HUMIRA PEN 40 MG/0.8 ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HUMIRA(CF) 20 MG/0.2 ML SYRINGE, is $3366.1230 per EA — about 0% below HUMIRA PEN 40 MG/0.8 ML.
Who manufactures HUMIRA PEN 40 MG/0.8 ML?
HUMIRA PEN 40 MG/0.8 ML (NDC 00074433902) is labeled by AbbVie Inc., and CMS classifies it as a brand product.